Pancreatic Cancer Research

ResearcherGeorgetown University Medical CenterActive in the last 2 years

Keith Robert Unger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-5963-2565; OpenAlex author ID A5110576063. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2017: 2 papers · 2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 2 papers

Papers 9

  1. Extracellular vesicle-derived miRNA-182-5p educates macrophages towards an immunosuppressive phenotype in pancreatic cancer. Co-author DOI 10.1038/s41392-025-02559-3↗
  2. Vascular Resection, Reconstruction, and Divestment in Pancreatoduodenectomy: Expanding Boundaries in Pancreatic Cancer Surgery. Co-author DOI 10.3390/cancers18040577↗
  3. Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locall… Last author DOI 10.1007/s12029-023-00996-3↗
  4. Phase 1 Study of Hypofractionated Proton Beam Radiation Therapy in Adjuvant Pancreatic Cancer (PROTON-PANC). Last author DOI 10.1016/j.ijrobp.2023.09.015↗
  5. TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC. Co-author DOI 10.3390/cancers13246204↗
  6. Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer. Last author DOI 10.1007/s12029-016-9909-2↗
  7. Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.25212↗
  8. Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma. Last author DOI 10.1097/coc.0000000000000118↗
  9. Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Co-author DOI 10.18632/oncotarget.20324↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Benjamin Adam Weinberg · 3 shared papers, 2024–2026 · strength 0.69
  2. John Lindsay Marshall · 4 shared papers, 2017–2024 · strength 0.51
  3. Amrita K. Cheema · 4 shared papers, 2017–2026 · strength 0.48
  4. Aiwu Ruth He · 3 shared papers, 2017–2024 · strength 0.43
  5. Louis M. Weiner · 3 shared papers, 2017–2024 · strength 0.43
  6. Emily R. Winslow · 2 shared papers, 2024 · strength 0.37
  7. Marcus Smith Noel · 2 shared papers, 2024 · strength 0.37
  8. Baldev B. Singh · 2 shared papers, 2021–2026 · strength 0.34
  9. Partha P. Banerjee · 2 shared papers, 2021–2026 · strength 0.34
  10. Yuri Genyk · 1 shared paper, 2026 · strength 0.32
  11. Dimitrios Moris · 1 shared paper, 2026 · strength 0.32
  12. Nicole Libbey · 1 shared paper, 2024 · strength 0.18
  13. Shreyans Kumar Jain · 2 shared papers, 2018–2021 · strength 0.18
  14. Marie Kate Gurka · 2 shared papers, 2017–2018 · strength 0.14
  15. Michael Jon Pishvaian · 2 shared papers, 2017–2018 · strength 0.14
  16. Khyati Y. Mehta · 2 shared papers, 2017–2018 · strength 0.14
  17. Jill Palmer Smith · 1 shared paper, 2021 · strength 0.10
  18. Charles P. Hinzman · 1 shared paper, 2021 · strength 0.10
  19. Meena U. Rajagopal · 1 shared paper, 2021 · strength 0.10
  20. Jonathan W. Lischalk · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.